Document › Details

Epigenomics AG. (10/8/18). "Press Release: Capital Increase through Rights Issue with Subscription Rights of Existing Shareholders [NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAP

Organisations Organisation Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY)
  Group Epigenomics (Group)
  Organisation 2 Cathay Fortune International Co. Ltd. (CFIC)
Products Product Epi proColon® blood test
  Product 2 investment banking
Person Person Vogt, Peter (Epigenomics 201601 Investor + Public Relations)
     


   
Record changed: 2019-06-09

Advertisement

[iito] Business Intelligence – The Elephants Are Coming 560x91px

More documents for Epigenomics (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture [iito] – Putting Information into Context 600x60px




» top